DANESE, SILVIO
 Distribuzione geografica
Continente #
EU - Europa 15.593
AS - Asia 15.518
NA - Nord America 10.734
SA - Sud America 5.533
AF - Africa 434
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 47.858
Nazione #
US - Stati Uniti d'America 10.117
RU - Federazione Russa 9.214
SG - Singapore 5.213
BR - Brasile 4.592
CN - Cina 4.251
HK - Hong Kong 2.299
VN - Vietnam 1.794
SE - Svezia 1.490
IT - Italia 1.424
FR - Francia 855
DE - Germania 591
BD - Bangladesh 525
FI - Finlandia 427
GB - Regno Unito 378
AR - Argentina 362
RO - Romania 293
CA - Canada 282
IN - India 258
ID - Indonesia 203
NL - Olanda 181
AT - Austria 177
EC - Ecuador 168
JP - Giappone 160
MX - Messico 160
ZA - Sudafrica 148
IQ - Iraq 118
TR - Turchia 118
CO - Colombia 110
ES - Italia 99
PY - Paraguay 90
PL - Polonia 89
CZ - Repubblica Ceca 84
PK - Pakistan 74
MA - Marocco 68
VE - Venezuela 68
UZ - Uzbekistan 66
UA - Ucraina 61
EG - Egitto 57
SA - Arabia Saudita 55
IE - Irlanda 53
CL - Cile 46
PE - Perù 42
UY - Uruguay 42
TN - Tunisia 38
MY - Malesia 34
NP - Nepal 33
DZ - Algeria 32
AE - Emirati Arabi Uniti 31
AU - Australia 28
JO - Giordania 28
AZ - Azerbaigian 27
IL - Israele 27
JM - Giamaica 25
KE - Kenya 25
DO - Repubblica Dominicana 23
PH - Filippine 23
TT - Trinidad e Tobago 23
IR - Iran 21
PT - Portogallo 21
HN - Honduras 20
TW - Taiwan 19
KZ - Kazakistan 18
LT - Lituania 18
KR - Corea 17
OM - Oman 17
BE - Belgio 16
MD - Moldavia 16
AL - Albania 14
GT - Guatemala 14
PA - Panama 14
CH - Svizzera 13
CR - Costa Rica 13
KW - Kuwait 13
RS - Serbia 13
BG - Bulgaria 12
BH - Bahrain 12
SN - Senegal 12
SV - El Salvador 12
ET - Etiopia 11
LB - Libano 10
NI - Nicaragua 10
BO - Bolivia 9
EU - Europa 9
GR - Grecia 9
CI - Costa d'Avorio 8
BY - Bielorussia 7
CY - Cipro 7
SI - Slovenia 7
BB - Barbados 6
KH - Cambogia 6
NG - Nigeria 6
PS - Palestinian Territory 6
TH - Thailandia 6
HU - Ungheria 5
KG - Kirghizistan 5
LV - Lettonia 5
QA - Qatar 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
BA - Bosnia-Erzegovina 4
Totale 47.775
Città #
Hong Kong 2.268
Moscow 2.266
Singapore 2.154
Ashburn 1.202
Dallas 1.139
San Jose 1.013
Hefei 841
Shanghai 794
Lauterbourg 725
Lawrence 703
Princeton 700
Ho Chi Minh City 696
New York 522
Beijing 505
Hanoi 382
São Paulo 365
Helsinki 350
Los Angeles 288
Milan 236
Santa Clara 170
Nuremberg 156
Rio de Janeiro 143
Orem 142
Munich 109
Rome 102
Atlanta 98
Council Bluffs 98
Brasília 93
Montreal 93
Tokyo 90
Belo Horizonte 88
Chicago 88
London 80
Vienna 80
Campinas 75
Olomouc 75
Da Nang 74
Haiphong 74
Curitiba 73
Brooklyn 72
Frankfurt am Main 72
Porto Alegre 72
Warsaw 70
Denver 68
Johannesburg 64
Tashkent 61
Houston 58
Salvador 58
Chennai 56
Manchester 56
Guangzhou 55
Boardman 54
Guayaquil 54
Quito 54
Biên Hòa 53
Phoenix 53
San Francisco 53
Stockholm 52
Baghdad 50
Buffalo 50
Buenos Aires 48
Dublin 47
Poplar 47
Naples 46
Dhaka 45
Mexico City 43
Toronto 43
Guarulhos 42
Lappeenranta 42
Amsterdam 41
Seattle 41
Hangzhou 37
Ribeirão Preto 37
Bologna 36
Hải Dương 36
Cape Town 35
Montevideo 35
Mumbai 35
Asunción 34
Goiânia 33
Boston 32
Lima 32
Manaus 32
Tianjin 32
Jakarta 31
Recife 31
Santo André 31
Thái Bình 31
Ankara 30
Borås 29
Fortaleza 29
Istanbul 29
Sorocaba 29
Turku 28
Baku 27
Amman 26
Caxias do Sul 26
Shenzhen 25
Juiz de Fora 24
Uberlândia 24
Totale 21.766
Nome #
Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease 1.528
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 747
Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines 438
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 294
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 225
Inflammation and coagulation in inflammatory bowel disease: The clot thickens 189
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 172
VAC-Stent in the Treatment of Post-Esophagectomy Anastomotic Leaks: A New “Kid on the Block” Who Marries the Best of Old Techniques—A Review 155
The Endoscopic Management of Zenker’s Diverticulum: A Comprehensive Review 151
Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis 148
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE 147
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 145
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 141
Crohn's disease 141
Long-term Efficacy of Vedolizumab for Crohn's Disease 141
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 137
Correction to: Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management 134
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 122
Inflammation and malnutrition in inflammatory bowel disease 120
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study 118
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 118
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 118
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 117
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 116
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 115
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis 114
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 113
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 111
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 110
Venous Thromboembolism in Patients with Neuroendocrine Neoplasms: A Systematic Review of Incidence, Types, and Clinical Outcomes 109
Unraveling the pathogenesis of Barrett’s esophagus and esophageal adenocarcinoma: the “omics” era 109
The Role of IL-23 Inhibitors in Crohn’s Disease 107
Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art 107
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study 107
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis 106
Imaging in Gastroparesis: Exploring Innovative Diagnostic Approaches, Symptoms, and Treatment 105
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation 105
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 105
Ustekinumab as induction and maintenance therapy for Crohn's disease 104
Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: a matched case-control study 103
Inflammatory Bowel Disease and Colorectal Cancer 103
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience 98
New therapeutic avenues in ulcerative colitis: thinking out of the box 98
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 98
Endoscopic Management of Post-Esophagectomy Delayed Gastric Conduit Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures 98
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 97
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT 97
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 96
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 96
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial 95
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 95
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 95
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 93
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 92
Dual-channel endoscope for double-traction endoscopic device-assisted full-thickness resection of rectal superficial tumor 92
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 92
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 92
A PROSPECTIVE, SINGLE CENTER STUDY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OF RECTAL LST LESIONS > 3 CM BY USING AN INNOVATIVE CONCEPT OF INJECTING AND CUTTING: THE WATER-JET HYBRID-KNIFE (ESD-H) 92
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease 92
The role of diet and lifestyle in early-onset colorectal cancer: A systematic review 92
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis 91
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 91
Clinical and biological heterogeneity of Grade 2 digestive neuroendocrine neoplasms: prognostic significance of the 10% Ki-67 index cutoff and implications for treatment strategies. A longitudinal study 91
Clinical Pathologic Challenge Saxophone Penis: Challenge 91
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 91
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 90
The role of filgotinib in ulcerative colitis and Crohn's disease 90
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis 90
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting 89
Correction to: Understanding the therapeutic toolkit for inflammatory bowel disease (Nature Reviews Gastroenterology & Hepatology, (2025), 22, 6, (371-394), 10.1038/s41575-024-01035-7) 89
Endoscopic Submucosal Dissection (ESD) for the Management of Fibrotic Non-Lifting Colorectal Lesions (NLCLs): Results from a Large Multicenter Retrospective Study 88
The Role of Fecal Microbiota Transplantation in IBD 88
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 88
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 88
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 87
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 87
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX (R) (Cortiment (R)(MMX (R))) for active, mild-to-moderate ulcerative colitis 87
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines 87
Adalimumab in active ulcerative colitis: A "real-life" observational study 87
Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey 86
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques 86
A Prospective Comparison Between 1.5t Magnetic Resonance and 3t Magnetic Resonance in Ileo-Colonic Crohn's Disease: A Single Center Experience 86
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials 85
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis 85
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease 85
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 83
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 83
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies 83
Small Bowel Cancer in Crohn’s Disease 82
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases 82
Biological agents for ulcerative colitis : Hypes and hopes 82
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 82
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 82
A snapshot of the ongoing clinical research on COVID-19 82
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes 82
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study 82
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 81
A prospective multi-centre observational cohort study assessing the effectiveness of Budesonide MMX (R) for mild-to-moderate ulcerative colitis 80
A PROSPECTIVE MULTICENTER OBSERVATIONAL COHORT STUDY ASSESSING THE EFFECTIVENESS OF BUDESONIDE MMX (R) FOR MILD-TO-MODERATE ULCERATIVE COLITIS 80
Clinical Pathologic Challenge Saxophone Penis: Challenge 79
Totale 12.923
Categoria #
all - tutte 312.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 312.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022961 0 0 0 810 16 17 7 5 23 23 15 45
2022/20233.362 1.824 645 74 12 14 363 54 136 179 20 13 28
2023/20241.129 31 38 62 52 54 196 26 70 2 45 107 446
2024/202510.277 1.159 43 133 88 80 659 1.838 1.057 1.983 1.802 653 782
2025/202633.153 2.473 2.248 2.300 4.520 2.224 841 2.412 2.146 8.381 1.567 2.056 1.985
Totale 48.885